0001144204-14-010903.txt : 20140221 0001144204-14-010903.hdr.sgml : 20140221 20140221060420 ACCESSION NUMBER: 0001144204-14-010903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140219 FILED AS OF DATE: 20140221 DATE AS OF CHANGE: 20140221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001411879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870324697 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-964-5123 MAIL ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: North Horizon, Inc. DATE OF NAME CHANGE: 20070910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Damaj Bassam CENTRAL INDEX KEY: 0001478733 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52991 FILM NUMBER: 14631576 MAIL ADDRESS: STREET 1: C/O BIO-QUANT, INC. STREET 2: 6330 NANCY RIDGE DRIVE, SUITE 103 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 v369250_form4.xml FORM 4 X0306 4 2014-02-19 0 0001411879 INNOVUS PHARMACEUTICALS, INC. INNV 0001478733 Damaj Bassam 8204 CAMINITO SANTA LUZ WEST 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92127 US 1 1 1 0 President and CEO Common Stock 2014-02-19 4 C 0 1190411 0 A 1708265 D Common Stock 129393 I By spouse Restricted Stock Unit Common Stock 852272 6852272 D Conversion of January 15, 2103 Line of Credit 8% Debenture at $0.40 per share. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Issued as a year end bonus pursuant to Reporting Person's employment agreement. The Reporting Person was granted a fully vested Restricted Stock Unit awarded on February 6, 2014. The Restricted Stocks Units will settle upon the earliest to occur of (1) the Reporting Person's service termination date, (ii) a change in control or (iii) February 6, 2021 /s/Randy Berholtz, Attorney-In-Fact 2014-02-20